In recent years, converging healthcare trends have been creating more empowered patients. Before the pandemic, patients could already monitor their own condition through connected devices such as glucose monitors for diabetes. Self-administration of injectable medication had become more prevalent; the development of biologics for subcutaneous administration coincided with the need to treat rising cases of chronic diseases, and an ageing population presenting comorbidities. Michael Earl at Owen Mumford Ltd discusses the benefits of supported patient self-care and self-administration.